Yuvraj

Gilead Secures GH31 Global Rights in $80M Oncology Deal

Gilead Sciences has added another synthetic lethal asset to its oncology portfolio, agreeing to pay $80 million upfront to obtain global rights to a...

AstraZeneca Breztri Reports Positive Phase III Trial Results

Results from the Phase III KALOS and LOGOS trials evaluating AstraZeneca Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) in patients with uncontrolled asthma have...

Weight-Loss Pills Mark a Turning Point for Pharma Industry

The global pharmaceutical industry is entering a pivotal phase in obesity therapeutics as companies accelerate the transition from injectable GLP-1 drugs to oral weight-loss...

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data

Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.

The Strategic Value of Editorially Curated Drug Databases

While raw data is abundant, the strategic value of drug information lies in editorial curation, ensuring that every interaction, dosage, and safety alert is verified by experts.

The Evolving Role of Medical Information in the Digital Pharma Era

The transformation of medical information services into digital ecosystems has revolutionized how healthcare providers and patients access vital drug safety and efficacy data.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read